Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
about
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy SubjectsCannabis Therapeutics and the Future of NeurologyCannabidiol for Treatment of Childhood Epilepsy-A Cross-Sectional SurveyA prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome
P2860
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
@en
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
@nl
type
label
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
@en
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
@nl
prefLabel
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
@en
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
@nl
P2093
P2860
P1433
P1476
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
@en
P2093
Anup D Patel
Cynthia L Harden
Elizabeth A Thiele
GWPCARE1 Part A Study Group
Gilmour Morrison
Kenneth Sommerville
Matthew H Wong
Richard Appleton
Sam Greenwood
P2860
P304
e1204-e1211
P356
10.1212/WNL.0000000000005254
P407
P577
2018-03-14T00:00:00Z